FDA Will Inspect Guidant Facilities; Design Change Guidance On Horizon
This article was originally published in The Gray Sheet
Executive Summary
FDA is planning "a comprehensive, onsite inspection" of Guidant's manufacturing facilities following the firm's recent recalls of several implantable defibrillators and pacemakers, an agency spokesperson said